Bailard’s Aspen Aerogels ASPN Stock Holding History

Bailard’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,300	Closed	-$91K	–	543
2019 Q3	$91K	Buy	+15,300	New	+$97.3K	0.01%	519

Other funds holding ASPN

George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Bailard's ASPN Position: Q4 2019 in Review

Bailard sold out of Aspen Aerogels (ASPN) in Q4 2019, closing a stake of 15,300 shares — an estimated $91K sold.

Bailard first reported a position in ASPN in Q3 2019 and held it in 1 quarter. The position peaked at $91K in Q3 2019. 48 funds tracked by Wall St. Rank hold ASPN as of Q4 2019.

Bailard reported no remaining Aspen Aerogels position as of Q4 2019 after selling out during the quarter.
Bailard sold 15,300 Aspen Aerogels shares in Q4 2019, an estimated $91K.
Bailard first reported a position in Aspen Aerogels in Q3 2019 and held it in 1 quarter.
Bailard's Aspen Aerogels position peaked at $91K in Q3 2019.
48 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2019.

Based on Bailard's 13F filing for Q4 2019, filed 31 Jan 2020.